These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects. Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A. Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095 [Abstract] [Full Text] [Related]
7. Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate. Fountain NB, Conry JA, Rodríguez-Leyva I, Gutierrez-Moctezuma J, Salas E, Coupez R, Stockis A, Lu ZS. Epilepsy Res; 2007 Apr; 74(1):60-9. PubMed ID: 17270398 [Abstract] [Full Text] [Related]
8. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid. Lee SY, Huh W, Jung JA, Yoo HM, Ko JW, Kim JR. Drug Des Devel Ther; 2015 Apr; 9():4559-63. PubMed ID: 26309401 [Abstract] [Full Text] [Related]
9. Pharmacokinetic study of levetiracetam in children. Pellock JM, Glauser TA, Bebin EM, Fountain NB, Ritter FJ, Coupez RM, Shields WD. Epilepsia; 2001 Dec; 42(12):1574-9. PubMed ID: 11879369 [Abstract] [Full Text] [Related]
12. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage. Mink S, Muroi C, Seule M, Bjeljac M, Keller E. Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756 [Abstract] [Full Text] [Related]
13. Population pharmacokinetics of levetiracetam in Japanese and Western adults. Pigeolet E, Jacqmin P, Sargentini-Maier ML, Stockis A. Clin Pharmacokinet; 2007 Oct; 46(6):503-12. PubMed ID: 17518509 [Abstract] [Full Text] [Related]
14. Isobolographic characterization of interactions of levetiracetam with the various antiepileptic drugs in the mouse 6 Hz psychomotor seizure model. Wojda E, Wlaz A, Patsalos PN, Luszczki JJ. Epilepsy Res; 2009 Oct; 86(2-3):163-74. PubMed ID: 19596559 [Abstract] [Full Text] [Related]
15. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas. Fay MA, Sheth RD, Gidal BE. Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308 [Abstract] [Full Text] [Related]
16. Haematological toxicity of Valproic acid compared to Levetiracetam in patients with glioblastoma multiforme undergoing concomitant radio-chemotherapy: a retrospective cohort study. Tinchon A, Oberndorfer S, Marosi C, Gleiss A, Geroldinger A, Sax C, Sherif C, Moser W, Grisold W. J Neurol; 2015 Jan; 262(1):179-86. PubMed ID: 25359262 [Abstract] [Full Text] [Related]
17. Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae Radix, in healthy volunteers. Chen LC, Chou MH, Lin MF, Yang LL. J Clin Pharm Ther; 2000 Dec; 25(6):453-9. PubMed ID: 11123499 [Abstract] [Full Text] [Related]
18. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy. Chhun S, Jullien V, Rey E, Dulac O, Chiron C, Pons G. Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400 [Abstract] [Full Text] [Related]
19. Comparison of reproductive effects of levetiracetam and valproate studied in prepubertal porcine ovarian follicular cells. Taubøll E, Gregoraszczuk EL, Tworzydø A, Wójtowicz AK, Ropstad E. Epilepsia; 2006 Sep; 47(9):1580-3. PubMed ID: 16981877 [Abstract] [Full Text] [Related]